They explained that IGF-I/-II normally binds to type I IGF receptor (IGF-IR), which mostly activates the adaptor protein insulin receptor substrate-1 (IRS-1), also found over-expressed in breast cancers. The gene discussed is IRS1; the disease is breast carcinoma.